The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin.
The global Skin Cancer market size is expected to reach US$ 727 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Skin Cancer in various end use industries. The expanding demands from the Hospital and Clinics, Diagnostic Centers and Cancer Research Institute,, are propelling Skin Cancer market. Cell carcinoma, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Squamous-cell Carcinoma segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Skin Cancer market, driven by demand from China, the second largest economy with some signs of stabilising, the Skin Cancer market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Skin Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Skin Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Skin Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Skin Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Skin Cancer covered in this report include Roche, Novartis, Sun Pharma, Elekta, Varian Medical Systems, Cannabis Science, Cellceutix, LEO Pharma and Moberg Pharma, etc.
The global Skin Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Roche
- Novartis
- Sun Pharma
- Elekta
- Varian Medical Systems
- Cannabis Science
- Cellceutix
- LEO Pharma
- Moberg Pharma
- Mylan
- Eli Lilly
- Bristol Myers Squibb
- Boehringer Ingelheim
- Aqua Pharmaceuticals
- Bausch Health
- Merck
Global Skin Cancer market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Skin Cancer market, Segment by Type:
- Cell carcinoma
- Squamous-cell Carcinoma
- Melanoma
- Others
Global Skin Cancer market, by Application:
- Hospital and Clinics
- Diagnostic Centers
- Cancer Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Skin Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Skin Cancer
1.1 Skin Cancer Market Overview
1.1.1 Skin Cancer Product Scope
1.1.2 Skin Cancer Market Status and Outlook
1.2 Global Skin Cancer Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Skin Cancer Market Size by Region (2018-2029)
1.4 Global Skin Cancer Historic Market Size by Region (2018-2023)
1.5 Global Skin Cancer Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Skin Cancer Market Size (2018-2029)
1.6.1 North America Skin Cancer Market Size (2018-2029)
1.6.2 Europe Skin Cancer Market Size (2018-2029)
1.6.3 Asia-Pacific Skin Cancer Market Size (2018-2029)
1.6.4 Latin America Skin Cancer Market Size (2018-2029)
1.6.5 Middle East & Africa Skin Cancer Market Size (2018-2029)
2 Skin Cancer Market by Type
2.1 Introduction
2.1.1 Cell carcinoma
2.1.2 Squamous-cell Carcinoma
2.1.3 Melanoma
2.1.4 Others
2.2 Global Skin Cancer Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Skin Cancer Historic Market Size by Type (2018-2023)
2.2.2 Global Skin Cancer Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Skin Cancer Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Skin Cancer Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Skin Cancer Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Skin Cancer Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Skin Cancer Revenue Breakdown by Type (2018-2029)
3 Skin Cancer Market Overview by Application
3.1 Introduction
3.1.1 Hospital and Clinics
3.1.2 Diagnostic Centers
3.1.3 Cancer Research Institute
3.2 Global Skin Cancer Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Skin Cancer Historic Market Size by Application (2018-2023)
3.2.2 Global Skin Cancer Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Skin Cancer Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Skin Cancer Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Skin Cancer Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Skin Cancer Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Skin Cancer Revenue Breakdown by Application (2018-2029)
4 Skin Cancer Competition Analysis by Players
4.1 Global Skin Cancer Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Skin Cancer as of 2022)
4.3 Date of Key Players Enter into Skin Cancer Market
4.4 Global Top Players Skin Cancer Headquarters and Area Served
4.5 Key Players Skin Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Skin Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Skin Cancer Products, Services and Solutions
5.1.4 Roche Skin Cancer Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Skin Cancer Products, Services and Solutions
5.2.4 Novartis Skin Cancer Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Sun Pharma
5.3.1 Sun Pharma Profile
5.3.2 Sun Pharma Main Business
5.3.3 Sun Pharma Skin Cancer Products, Services and Solutions
5.3.4 Sun Pharma Skin Cancer Revenue (US$ Million) & (2018-2023)
5.3.5 Elekta Recent Developments
5.4 Elekta
5.4.1 Elekta Profile
5.4.2 Elekta Main Business
5.4.3 Elekta Skin Cancer Products, Services and Solutions
5.4.4 Elekta Skin Cancer Revenue (US$ Million) & (2018-2023)
5.4.5 Elekta Recent Developments
5.5 Varian Medical Systems
5.5.1 Varian Medical Systems Profile
5.5.2 Varian Medical Systems Main Business
5.5.3 Varian Medical Systems Skin Cancer Products, Services and Solutions
5.5.4 Varian Medical Systems Skin Cancer Revenue (US$ Million) & (2018-2023)
5.5.5 Varian Medical Systems Recent Developments
5.6 Cannabis Science
5.6.1 Cannabis Science Profile
5.6.2 Cannabis Science Main Business
5.6.3 Cannabis Science Skin Cancer Products, Services and Solutions
5.6.4 Cannabis Science Skin Cancer Revenue (US$ Million) & (2018-2023)
5.6.5 Cannabis Science Recent Developments
5.7 Cellceutix
5.7.1 Cellceutix Profile
5.7.2 Cellceutix Main Business
5.7.3 Cellceutix Skin Cancer Products, Services and Solutions
5.7.4 Cellceutix Skin Cancer Revenue (US$ Million) & (2018-2023)
5.7.5 Cellceutix Recent Developments
5.8 LEO Pharma
5.8.1 LEO Pharma Profile
5.8.2 LEO Pharma Main Business
5.8.3 LEO Pharma Skin Cancer Products, Services and Solutions
5.8.4 LEO Pharma Skin Cancer Revenue (US$ Million) & (2018-2023)
5.8.5 LEO Pharma Recent Developments
5.9 Moberg Pharma
5.9.1 Moberg Pharma Profile
5.9.2 Moberg Pharma Main Business
5.9.3 Moberg Pharma Skin Cancer Products, Services and Solutions
5.9.4 Moberg Pharma Skin Cancer Revenue (US$ Million) & (2018-2023)
5.9.5 Moberg Pharma Recent Developments
5.10 Mylan
5.10.1 Mylan Profile
5.10.2 Mylan Main Business
5.10.3 Mylan Skin Cancer Products, Services and Solutions
5.10.4 Mylan Skin Cancer Revenue (US$ Million) & (2018-2023)
5.10.5 Mylan Recent Developments
5.11 Eli Lilly
5.11.1 Eli Lilly Profile
5.11.2 Eli Lilly Main Business
5.11.3 Eli Lilly Skin Cancer Products, Services and Solutions
5.11.4 Eli Lilly Skin Cancer Revenue (US$ Million) & (2018-2023)
5.11.5 Eli Lilly Recent Developments
5.12 Bristol Myers Squibb
5.12.1 Bristol Myers Squibb Profile
5.12.2 Bristol Myers Squibb Main Business
5.12.3 Bristol Myers Squibb Skin Cancer Products, Services and Solutions
5.12.4 Bristol Myers Squibb Skin Cancer Revenue (US$ Million) & (2018-2023)
5.12.5 Bristol Myers Squibb Recent Developments
5.13 Boehringer Ingelheim
5.13.1 Boehringer Ingelheim Profile
5.13.2 Boehringer Ingelheim Main Business
5.13.3 Boehringer Ingelheim Skin Cancer Products, Services and Solutions
5.13.4 Boehringer Ingelheim Skin Cancer Revenue (US$ Million) & (2018-2023)
5.13.5 Boehringer Ingelheim Recent Developments
5.14 Aqua Pharmaceuticals
5.14.1 Aqua Pharmaceuticals Profile
5.14.2 Aqua Pharmaceuticals Main Business
5.14.3 Aqua Pharmaceuticals Skin Cancer Products, Services and Solutions
5.14.4 Aqua Pharmaceuticals Skin Cancer Revenue (US$ Million) & (2018-2023)
5.14.5 Aqua Pharmaceuticals Recent Developments
5.15 Bausch Health
5.15.1 Bausch Health Profile
5.15.2 Bausch Health Main Business
5.15.3 Bausch Health Skin Cancer Products, Services and Solutions
5.15.4 Bausch Health Skin Cancer Revenue (US$ Million) & (2018-2023)
5.15.5 Bausch Health Recent Developments
5.16 Merck
5.16.1 Merck Profile
5.16.2 Merck Main Business
5.16.3 Merck Skin Cancer Products, Services and Solutions
5.16.4 Merck Skin Cancer Revenue (US$ Million) & (2018-2023)
5.16.5 Merck Recent Developments
6 North America
6.1 North America Skin Cancer Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Skin Cancer Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Skin Cancer Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Skin Cancer Market Dynamics
11.1 Skin Cancer Industry Trends
11.2 Skin Cancer Market Drivers
11.3 Skin Cancer Market Challenges
11.4 Skin Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
